World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02173275
Date of registration: 23/06/2014
Prospective Registration: No
Primary sponsor: Weill Medical College of Cornell University
Public title: Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia CREDENCE
Scientific title: Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Date of first enrolment: May 2014
Target sample size: 618
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02173275
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Canada China Italy Japan Korea, Republic of Latvia Netherlands United States
Contacts
Name:     Leslee J Shaw, PhD
Address: 
Telephone:
Email:
Affiliation:  Weill Medical College of Cornell University
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Age >18 years

2. Scheduled to undergo clinically-indicated non-emergent invasive coronary angiography

Exclusion Criteria:

1. Known CAD (myocardial infarction [MI], percutaneous coronary interventions [PCIs],
coronary artery bypass graft [CABG],)

2. Hemodynamic instability

3. Inability to provide written informed consent

4. Concomitant participation in another clinical trial in which subject is subject to
investigational drug or device

5. Pregnant state

6. Absolute contraindication to iodinated contrast due to prior near-fatal anaphylactoid
reaction (laryngospasm, bronchospasm, cardiorespiratory collapse, or equivalent)

7. Serum creatinine =1.7 mg/dl or Glomerular Filtration Rate <30 ml/min

8. Baseline irregular heart rhythm (e.g., atrial fibrillation, etc.)

9. Heart rate =100 beats per minute

10. Systolic blood pressure =90 mm Hg

11. Contraindications to ß blockers or nitroglycerin or adenosine

12. BMI >40 kg/m2



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Myocardial Ischemia
Intervention(s)
Primary Outcome(s)
Diagnostic accuracy of vessel territory-specific ischemia of an integrated stenosis-APC-FFRCT measure by CT [Time Frame: 48-60 months]
Secondary Outcome(s)
Post-PCI FFR prediction by FFRCT "virtual stenting" [Time Frame: 48-60 months]
Individual comparisons of APCs or FFRCT to MPI vessel-specific perfusion deficits or reduced MBF. [Time Frame: 48-60 months]
Secondary ID(s)
1309014313
R01HL118019
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Heart, Lung, and Blood Institute (NHLBI)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history